- Home
- PYPL vs GSK Comparison
PYPL vs GSK Comparison
Compare PYPL & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPL
- GSK
- Stock Information
- Founded
- PYPL 1998
- GSK 1715
- Country
- PYPL United States
- GSK United Kingdom
- Employees
- PYPL N/A
- GSK N/A
- Industry
- PYPL Business Services
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- PYPL Consumer Discretionary
- GSK Health Care
- Exchange
- PYPL Nasdaq
- GSK Nasdaq
- Market Cap
- PYPL 66.8B
- GSK 77.1B
- IPO Year
- PYPL 2002
- GSK N/A
- Fundamental
- Price
- PYPL $66.89
- GSK $40.85
- Analyst Decision
- PYPL Buy
- GSK Hold
- Analyst Count
- PYPL 30
- GSK 2
- Target Price
- PYPL $83.89
- GSK N/A
- AVG Volume (30 Days)
- PYPL 9.1M
- GSK 3.8M
- Earning Date
- PYPL 10-28-2025
- GSK 10-29-2025
- Dividend Yield
- PYPL N/A
- GSK 3.96%
- EPS Growth
- PYPL 12.89
- GSK N/A
- EPS
- PYPL 4.67
- GSK 1.13
- Revenue
- PYPL $32,292,000,000.00
- GSK $43,336,073,439.00
- Revenue This Year
- PYPL $6.01
- GSK $5.66
- Revenue Next Year
- PYPL $5.97
- GSK $5.13
- P/E Ratio
- PYPL $14.33
- GSK $17.49
- Revenue Growth
- PYPL 4.07
- GSK 0.59
- 52 Week Low
- PYPL $55.85
- GSK $31.72
- 52 Week High
- PYPL $93.66
- GSK $43.62
- Technical
- Relative Strength Index (RSI)
- PYPL 40.98
- GSK 59.28
- Support Level
- PYPL $65.24
- GSK $39.37
- Resistance Level
- PYPL $69.94
- GSK $41.53
- Average True Range (ATR)
- PYPL 1.42
- GSK 0.61
- MACD
- PYPL -0.16
- GSK 0.11
- Stochastic Oscillator
- PYPL 30.28
- GSK 76.38
About PYPL PayPal Holdings Inc.
PayPal was spun off from eBay in 2015 and provides electronic payment solutions to merchants and consumers, with a focus on online transactions. The company had 434 million active accounts at the end of 2024. The company also owns Venmo, a person-to-person payment platform.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.